Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1.

Xiang P, Wei W, Hofs N, Clemans-Gibbon J, Maetzig T, Lai CK, Dhillon I, May C, Ruschmann J, Schneider E, Rosten P, Hu K, Kuchenbauer F, Hoodless PA, Humphries RK.

Blood Adv. 2017 Nov 7;1(24):2225-2235. doi: 10.1182/bloodadvances.2017010355. eCollection 2017 Nov 14.

2.

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.

Schneider E, Staffas A, Röhner L, Malmberg ED, Ashouri A, Krowiorz K, Pochert N, Miller C, Wei SY, Arabanian L, Buske C, Döhner H, Bullinger L, Fogelstrand L, Heuser M, Döhner K, Xiang P, Ruschmann J, Petriv OI, Heravi-Moussavi A, Hansen CL, Hirst M, Humphries RK, Rouhi A, Palmqvist L, Kuchenbauer F.

Haematologica. 2018 Feb;103(2):246-255. doi: 10.3324/haematol.2017.177485. Epub 2017 Dec 7.

3.

Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells.

Maetzig T, Ruschmann J, Sanchez Milde L, Lai CK, von Krosigk N, Humphries RK.

Mol Ther Methods Clin Dev. 2017 Jun 1;6:54-65. doi: 10.1016/j.omtm.2017.05.007. eCollection 2017 Sep 15.

4.

A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking.

Maetzig T, Ruschmann J, Lai CK, Ngom M, Imren S, Rosten P, Norddahl GL, von Krosigk N, Sanchez Milde L, May C, Selich A, Rothe M, Dhillon I, Schambach A, Humphries RK.

Mol Ther. 2017 Mar 1;25(3):606-620. doi: 10.1016/j.ymthe.2016.12.005. Epub 2017 Jan 5.

5.

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.

Krowiorz K, Ruschmann J, Lai C, Ngom M, Maetzig T, Martins V, Scheffold A, Schneider E, Pochert N, Miller C, Palmqvist L, Staffas A, Mulaw M, Bohl SR, Buske C, Heuser M, Kraus J, O'Neill K, Hansen CL, Petriv OI, Kestler H, Döhner H, Bullinger L, Döhner K, Humphries RK, Rouhi A, Kuchenbauer F.

Blood Cancer J. 2016 Dec 9;6(12):e508. doi: 10.1038/bcj.2016.110. No abstract available.

6.

MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.

Gentner B, Pochert N, Rouhi A, Boccalatte F, Plati T, Berg T, Sun SM, Mah SM, Mirkovic-Hösle M, Ruschmann J, Muranyi A, Leierseder S, Argiropoulos B, Starczynowski DT, Karsan A, Heuser M, Hogge D, Camargo FD, Engelhardt S, Döhner H, Buske C, Jongen-Lavrencic M, Naldini L, Humphries RK, Kuchenbauer F.

Exp Hematol. 2015 Oct;43(10):858-868.e7. doi: 10.1016/j.exphem.2015.05.018. Epub 2015 Jul 8.

7.

The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.

Ruschmann J, Antignano F, Lam V, Snyder K, Kim C, Essak M, Zhang A, Lin AH, Mali RS, Kapur R, Krystal G.

J Immunol. 2012 Apr 15;188(8):3839-50. doi: 10.4049/jimmunol.1003875. Epub 2012 Mar 19.

8.

Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.

Kuchenbauer F, Mah SM, Heuser M, McPherson A, Rüschmann J, Rouhi A, Berg T, Bullinger L, Argiropoulos B, Morin RD, Lai D, Starczynowski DT, Karsan A, Eaves CJ, Watahiki A, Wang Y, Aparicio SA, Ganser A, Krauter J, Döhner H, Döhner K, Marra MA, Camargo FD, Palmqvist L, Buske C, Humphries RK.

Blood. 2011 Sep 22;118(12):3350-8. doi: 10.1182/blood-2010-10-312454. Epub 2011 May 31.

9.

SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.

Kuroda E, Antignano F, Ho VW, Hughes MR, Ruschmann J, Lam V, Kawakami T, Kerr WG, McNagny KM, Sly LM, Krystal G.

J Immunol. 2011 Jan 1;186(1):323-32. doi: 10.4049/jimmunol.1002778. Epub 2010 Dec 3.

10.

Role of SHIP in cancer.

Hamilton MJ, Ho VW, Kuroda E, Ruschmann J, Antignano F, Lam V, Krystal G.

Exp Hematol. 2011 Jan;39(1):2-13. doi: 10.1016/j.exphem.2010.11.002. Epub 2010 Nov 4. Review.

PMID:
21056081
11.

SHIP negatively regulates Flt3L-derived dendritic cell generation and positively regulates MyD88-independent TLR-induced maturation.

Antignano F, Ibaraki M, Ruschmann J, Jagdeo J, Krystal G.

J Leukoc Biol. 2010 Nov;88(5):925-35. doi: 10.1189/jlb.1209825. Epub 2010 Aug 18.

PMID:
20720161
12.

Comprehensive microRNA expression profiling of the hematopoietic hierarchy.

Petriv OI, Kuchenbauer F, Delaney AD, Lecault V, White A, Kent D, Marmolejo L, Heuser M, Berg T, Copley M, Ruschmann J, Sekulovic S, Benz C, Kuroda E, Ho V, Antignano F, Halim T, Giambra V, Krystal G, Takei CJ, Weng AP, Piret J, Eaves C, Marra MA, Humphries RK, Hansen CL.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15443-8. doi: 10.1073/pnas.1009320107. Epub 2010 Aug 11.

13.

Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.

Ruschmann J, Ho V, Antignano F, Kuroda E, Lam V, Ibaraki M, Snyder K, Kim C, Flavell RA, Kawakami T, Sly L, Turhan AG, Krystal G.

Exp Hematol. 2010 May;38(5):392-402, 402.e1. doi: 10.1016/j.exphem.2010.03.010. Epub 2010 Mar 18.

PMID:
20304029
14.

SHIP is required for dendritic cell maturation.

Antignano F, Ibaraki M, Kim C, Ruschmann J, Zhang A, Helgason CD, Krystal G.

J Immunol. 2010 Mar 15;184(6):2805-13. doi: 10.4049/jimmunol.0903170. Epub 2010 Feb 12.

15.

SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils.

Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, Rauh MJ, Antov A, Flavell RA, Sly LM, Krystal G.

J Immunol. 2009 Sep 15;183(6):3652-60. doi: 10.4049/jimmunol.0900864. Epub 2009 Aug 26.

16.

Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.

Ong CJ, Ming-Lum A, Nodwell M, Ghanipour A, Yang L, Williams DE, Kim J, Demirjian L, Qasimi P, Ruschmann J, Cao LP, Ma K, Chung SW, Duronio V, Andersen RJ, Krystal G, Mui AL.

Blood. 2007 Sep 15;110(6):1942-9. Epub 2007 May 14.

17.

The role of SHIP in macrophages.

Sly LM, Ho V, Antignano F, Ruschmann J, Hamilton M, Lam V, Rauh MJ, Krystal G.

Front Biosci. 2007 May 1;12:2836-48. Review.

PMID:
17485263
18.

Re: the terminology issue for myeloid-derived suppressor cells.

Krystal G, Sly L, Antignano F, Ho V, Ruschmann J, Hamilton M.

Cancer Res. 2007 Apr 15;67(8):3986. No abstract available.

19.

cDNA subtraction cloning reveals novel genes whose temporal and spatial expression indicates association with trophoblast invasion.

Hemberger M, Himmelbauer H, Ruschmann J, Zeitz C, Fundele R.

Dev Biol. 2000 Jun 1;222(1):158-69.

20.

[Free border movement of the mandible after operations for prognathism].

Otten JE, Ruschmann JA, Joos U.

Inf Orthod Kieferorthop. 1991;23(3):397-405. German. No abstract available.

PMID:
1818893

Supplemental Content

Loading ...
Support Center